Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| 發表在: | Springer eBooK. |
|---|---|
| 企業作者: | |
| 其他作者: | |
| 格式: | Electronic Resource |
| 語言: | English |
| 出版: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| 叢編: | Issues in children's and families' lives
no.2 |
| 主題: | |
| 在線閱讀: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |